Glycation of collagen: The basis of its central role in the late complications of ageing and diabetes

International Journal of Biochemistry and Cell Biology

Volumn 28, Issue 12, 1996, Pages 1297-1310

  Paul, R G ^a   Bailey, A J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

AGE; Collagen; Cross linking; Glycation

Indexed keywords

COLLAGEN; ELASTIN;

AGED; AGING; CARDIOVASCULAR SYSTEM; CELL STRUCTURE; DIABETES MELLITUS; GLYCATION; HUMAN; HYPERGLYCEMIA; KIDNEY PARENCHYMA; MEMBRANE PERMEABILITY; MORBIDITY; MORTALITY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN MODIFICATION; RETINA CAPILLARY; REVIEW;

AGING; ANIMALS; ARGININE; COLLAGEN; CROSS-LINKING REAGENTS; DIABETES COMPLICATIONS; DIABETES MELLITUS; ELASTIN; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMIDAZOLES; LYSINE; MAILLARD REACTION; MALONDIALDEHYDE; NORLEUCINE; PYRROLES;

EID: 0030477949     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(96)00079-9     Document Type: Review

References (98)

1. ε-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J. biol. Chem. 261, 4889-4894.
2. ε-(carboxymethyl)lysine formation by direct addition of glyoxal to lysine during the Maillard reaction. Bioorg. Med. Chem. Letts 5, 2161-2162.
3. Andreassen T. T., Seyer-Hansen K. and Bailey A. J. (1981) Thermal stability, mechanical properties and reducible cross-links of rat tail tendon in experimental diabetes. Biochim. Biophys. Acta 677, 313-317.
4. Bailey A. J., Light N. D. and Atkins E. D. T. (1980) Chemical cross-linking restrictions on models for the molecular organisation of the collagen fibre. Nature (Lond.) 288, 408-410.
5. Bailey A. J., Sims T. J., Avery N. C. and Halligan E. P. (1995) Non-enzymic glycation of fibrous collagen: reaction products of glucose and ribose. Biochem. J. 305, 385-390.
6. Bailey A. J., Sims T. J., Avery N. C. and Miles C. A. (1993) Chemistry of collagen cross-links-glucose-mediated covalent cross-linking of type-IV collagen in lens capsules. Biochem. J. 296, 489-496.
7. Bailey A. J. (1995) Non-enzymic glycation of elastin in molecular biology and pathology of elastin. Ciba Symposium No 192, 302-304.
8. Barnes M. J., Bailey A. J., Gordon J. L. and MacIntyre D. J. (1980) Platelet aggregation by basement membrane-associated collagens. Throm. Res. 18, 375-388.
9. Baynes J. W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412.
10. Baynes J. W., Watkins N. G., Fisher C. I., Hull C. J., Patrick J. S., Ahmed M. U., Dunn J. A. and Thorpe S. R. (1989) The Amadori product on protein: structure and reactions. In The Maillard Reaction in Aging, Diabetes and Nutrition (Eds Baynes J. W. and Monnier V. M.), pp. 43-67. A. R. Liss, New York.
11. Beppu M., Fukata Y. and Kikugawa K. (1988) Interaction of malondialdehyde-modified bovine serum-albumin and mouse peritoneal-macrophages. Chem. Pharm. Bull. 36, 4519-4526.
12. Bookchin R. M. and Gallop P. M. (1968). Biochem. Biophys. Res. Comm. 32, 86-93.
13. Brownlee M., Vlassara H., Kooney A., Ulrich P. and Cerami A. (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232, 1629-1632.
14. Bucala R., Tracey K. J. and Cerami A. (1991) Advanced glycosylation products quench nitric-oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 87, 2, 432-438.
15. Buckingham B. A. and Reiser K. M. (1990) Relationship between the content of lysyl-oxidase cross-links in skin collagen, non-enzymatic glycosylation and long term complications in type I diabetes mellitus. J. Clin. Invest. 86, 1046-1054.
16. Cerami A., Vlassara H. and Brownlee M. (1987) Glucose and aging. Sci. Am. 256, 82-88.
17. Chace K. V., Carubelli R. and Nordquist R. E. (1991) The role of non-enzymatic glycosylation, transition metals, and free radicals in the formation of collagen aggregates. Arch. Biochem. Biophys 288, 473-480.
18. Chang J. C. F., Ulrich P. C., Bucala R. and Cerami A. (1985) Detection of an advanced glycosylation product bound to protein in situ. J. biol. Chem. 260, 7970-7974.
19. Cheng R. Z., Tsunehiro J., Uchida K. and Kawasaki S. (1991) Oxidative damage of glycated protein in the presence of transition metal ions. Agric. Biol. Chem. 55, 1993-1998.
20. DeCaprio A. P. (1986) Mechanism of in vitro pyrrole adduct autoxidation in 2,5-hexanedione treated protein. Mol. Pharmacol. 30, 452-458.
21. Diabetes Control and Complications Trial (1993) The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986.
22. ε-(carboxymethyl)-hydroxylysine in human skin collagen. Biochemistry 30, 1205-1210.
23. ε-(carboxymethyl) lysine in lens proteins. Biochemistry 28, 9464-9468.
24. Dyer D. G., Blackledge J. A., Thorpe S. R. and Baynes J. W. (1991) Formation of pentosidine during non-enzymatic browning of proteins by glucose-identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J. biol. Chem. 266, 11654-11660.
25. Dyer D. G., Dunn J. A., Thorpe S. R., Bailie K. E., Lyons T. J., McCance D. R. and Baynes J. W. (1993) Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 91, 2463-2469.
26. Esterbauer H., Schuar R. J. and Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Rad. Biol. Med. 11, 81-128.
27. Fu M.-X., Thorpe S. R. and Baynes J. W. (1994a) Effects of aspirin on glycation, glycoxidation and cross-linking of collagen. In Maillard Reactions in Chemistry, Food, and Health (Eds Labuza T. P., Reineccius G. A., Monnier V. M., O'Brien J. and Baynes J. W.), pp. 95-100. The Royal Society of Chemistry, Cambridge.
28. Fu M.-X., Wells-Knecht K. J., Blackledge J. A., Lyons T. J., Thorpe S. R. and Baynes J. W. (1994b) Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 43, 676-683.
29. Fu M. X., Knecht K. J., Thorpe S. R. and Baynes J. W. (1992) Role of oxygen in cross-linking and chemical modification of collagen by glucose. Diabetes 41, Suppl. 2, 42-48.
30. Gerhardinger C., Lapolla A., Crepaldi G., Fedele D., Ghezzo E., Seraglia R. and Traldi P. (1990) Evidence of acid hydrolysis as responsible for 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole (FFI) production. Clin. Chim. Acta 189, 335-340.
31. Glomb M. A. and Monnier V. M. (1995) Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J. biol. Chem. 270, 10017-10026.
32. Graham D. G., Anthony D. C., Boekelheide K., Maschmann N. A., Richards R. G., Wolfram J. W. and Shaw B. R. (1982) Studies of the molecular pathogenisis of hexane neuropathy II. Evidence that pyrrole derivatization of lysyl residues leads to protein cross-linking. Toxicol. Appl. Pharmacol. 64, 415-422.
33. Grandhee S. K. and Monnier V. M. (1991) Mechanism of formation of the Maillard protein cross-link pentosidine-glucose, fructose, and ascorbate as pentosidine precursors. J. biol. Chem. 266, 11649-11653.
34. Guitton J. D., Le-Pape A., Sizaret P. Y. and Muh J. P. (1981) Effects of in vitro N-glucosylation on type I collagen fibrillogenesis. Biosci. Rep. 1, 945-954.
35. Haitoglou C. S., Tsilibary E. C., Brownlee M. and Charonis A. S. (1992) Altered cellular interactions between endothelial cells and non-enzymatically glucosylated laminin/type-IV collagen. J. biol. Chem. 267, 12404-12407.
36. Hartog M. G. L., Feskins E. J. M. and Hollman P. C. M. (1993) Dietry antioxidant flavonoids and coronary heart disease. Lancet 342, 1007-1011.
37. Hayase F., Nagaraj R. H., Miyata S., Njoroge F. G. and Monnier V. M. (1989) Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J. biol. Chem. 264, 3758-3764.
38. Hayashi T. and Namiki M. (1986) Role of sugar fragmentation in the Maillard reaction. In Amino-carbonyl Reactions in Food and Biological Systems (Eds Fujimaki M., Namiki M. and Kato H.), pp. 29-38. Elsevier, Amsterdam.
39. Henle T. and Klostermeyer H. (1993) Determination of protein bound 2-amino-6-(2-formyl-1-pyrrolyl)-hexanoic acid (pyrraline) by ion-exchange chromatography and photodiode array detection. Z. Lebensmittelunters. U.-Forsch. 196, 1-4.
40. Hicks M., Delbridge L., Yue D. K. and Reeve T. S. (1988) Catalysis of lipid peroxidation by glucose and glycosylated collagen. Biochem. Biophys Res. Comm. 151, 49-55.
41. Hipkiss A. R., Michaelis J. and Syrris P. (1995) Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein cross-linking agent. FEBS Lett. 371, 81-85.
42. Hirsch J., Baines C. L. and Feather M. S. (1992) X-ray structure of 3-amino 5 substituted triazines produced by the reaction of 3-deoxyglucose with aminoguanidine. J. Carb. Res. 11, 891-901.
43. Horiuchi S., Shiga M., Araki N., Takata K., Saitoh M. and Morino Y. (1988) Evidence against in vivo presence of 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole, a major fluorescent advanced end product generated by non-enzymatic glycosylation. J. biol. Chem. 263, 18821-18826.
44. Huby R. and Harding J. J. (1988) Non-enzymic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathione. Exp. Eye Res. 47, 53-59.
45. Kato H., Hayase F., Shin D. B., Oimomi M. and Baba S. (1989) 3-deoxyglucosone, an intermediate product in the Maillard reaction. In The Maillard Reaction in Aging, Diabetes, and Nutrition (Eds Baynes J. W. and Monnier V. M.), pp. 69-84. A. R. Liss, New York.
46. Kent M. J. C., Light N. D. and Bailey A. J. (1985) Evidence for glucose mediated covalent cross-linking of collagen after glycosylation in vitro. Biochem. J. 225, 745-752.
47. Kikugawa K., Takayanagi K. and Watanabe S. (1985) Polylysines modified with malonaldehyde, hydroperoxylinoleic acid and monofunctional aldehydes. Chem. Pharm. Bull. 33, 5437-5444.
48. Knecht K. J., Feather M. S. and Baynes J. W. (1992) Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma-evidence for intermediate stages of the Maillard reaction in vivo. Arch. Biochem. Biophys 294, 130-137.
49. Lapolla A., Gerhardinger C., Ghezzo E., Seraglia R., Sturaro A., Crepaldi G., Fedele D. and Traldi P. (1990a) Identification of furoyl-containing advanced glycation products in collagen samples from diabetic and healthy rats. Biochim. Biophys Acta 1033, 13-18.
50. Lapolla A., Gerhardinger C., Pelli B., Sturaro A., Del Favero E., Traldi P., Crepaldi G. and Fedele D. (1990b) Absence of brown product FF1 in non-diabetic and diabetic rat collagen. Diabetes 39, 57-61.
51. LePape A., Guitton J.-D. and Muh J.-P. (1984) Distribution of non-enzymatically bound glucose in in vivo and in vitro type I collagen molecules. FEBS Letts. 170, 23-27.
52. LePape A., Gutman N., Guitton J.-D., LeGrand Y., Fauvel F. and Muh J.-P. (1983). Haemostasis 88, 36-41.
53. Lewis B. S. and Harding J. J. (1990) The effects of aminoguanidine on the glycation (non-enzymatic glycosylation) of lens proteins. Exp. Eye Res. 50, 463-467.
54. Makita Z., Vlassara H., Cerami A. and Bucala R. (1992) Immunochemical detection of advanced glycosylation end products in vivo. J. biol. Chem. 267, 5133-5138.
55. Marion M. S. and Carlson E. C. (1994) Immunoelectron microscopic analyses of Maillard reaction products in bovine anterior lens capsule and Descemets membrane. Biochim. Biophys Acta-Biomembranes 1191, 33-42.
56. Miles C. A., Burjanadze T. V. and Bailey A. J. (1995) The kinetics of the thermal denaturation of collagen in unrestrained rat tail tendon determined by differential scanning calorimetry, J. Mol. Biol. 245, 437-446.
57. Miyata S. and Monnier V. M. (1992) Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline. J. Clin. Invest. 89, 1102-1112.
58. Monnier V. M., Vishwana V., Frank K. E., Elmets C. A., Dauchot P. and Kohn R. R. (1986) Relation between complications of type-I diabetes-mellitus and collagen-linked fluorescence. N. Engl. J. Med. 314, 403-408.
59. Nagaraj R., Hayase F. and Monnier V. M. (1988) Immunological detection of pyrraline, an advanced glycosylation end-product of human lens crystallins. FASEB. J. 2, A1023.
60. Niwa T., Takeda N., Yoshizumi H., Tatematsu A., Ohara M., Tomiyama S. and Niimura K. (1993) Presence of 3-deoxyglucosone, a potent protein cross-linking intermediate of Maillard reaction, in diabetic serum. Biochem. Biophys Res. Comm. 196, 837-843.
61. Njoroge F. G., Fernandes A. A. and Monnier V. M. (1988) Mechanism of formation of the putative advanced glycosylation end product and protein cross-link 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole. J. biol. Chem. 263, 10646-10652.
62. Njoroge F. G. and Monnier V. M. (1989) The chemistry of the Maillard reaction under physiological conditions: a review. In The Maillard Reaction in Aging, Diabetes, and Nutrition (Eds Baynes J. W. and Monnier V. M.), pp. 85-107. A. R. Liss, New York.
63. Njoroge F. G., Sayre L. M. and Monnier V. M. (1987) Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr. Res. 167, 211-220.
64. Nyhammer T., Olsson K. and Pernemalm P. A. (1983) On the formation of 2-acylpyrroles and 3-pyridinols in the Maillard reaction through Strecker degradation. Acta Chem. Scand. (Series B-Organic Chemistry and Biochemistry) 37, 879-889.
65. Ou P. M. and Wolff S. P. (1994) Aminoguanidine - a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem. Pharmacol. 46, 1139-1144.
66. Ozdemirler G., Mehmetcik G., Oztezcan S., Toker G., Sivas A. and Uysal M. (1995) Peroxidation potential and antioxidant activity of serum in patients with diabetes mellitus and myocardial infarction. Horm. Metab. Res. 27, 194-196.
67. Palinski W., Koschinsky T., Butler S. W., Miller E., Vlassara H., Cerami A. and Witzum J. L. (1995) Immmunological evidence for the presence of advanced glycosylation end products in atheroscelortic lesions of euglycemic rabbits. Arterioscler. Thromb. Vasc. Biol. 15, 571-582.
68. Pongor S., Ulrich P. C., Benscath F. A. and Cerami A. (1984) Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc. Natl Acad. Sci. 81, 2684-2688.
69. Portero-Otin M., Nagaraj R. H. and Monnier V. M. (1995) Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo. Biochem. Biophys Res. Comm. 1247, 74-80.
70. Rao G. N. and Cotlier E. (1988) Aspirin prevents the non-enzymatic glycosylation and carbamylation of the human eye lens crystallins in vitro. Biochem. Biophys Res. Comm. 151, 991-996.
71. Reddy S., Bichler J., Wellsknecht K. J., Thorpe S. R. and Baynes J. W. (1995) N-epsilon-(carboxymethyl)-lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 34, 10872-10878.
72. Reiser K. M., Amigable M. A. and Last J. A. (1992) Non-enzymatic glycation of type I collagen. The effects of aging on preferential glycation sites. J. biol. Chem. 267, 24207-24216.
73. Riley L. M. and Harding J. J. (1993) The reaction of malondialdehyde with lens proteins and the protective effect of aspirin. Biochim. Biophys Acta 1158, 107-112.
74. Robins S. P. and Bailey A. J. (1972) Age-related changes: the identification of reducible lysine-carbohydrate condensation products. Biochem. Biophys Res. Comm. 48, 76-84.
75. Schleicher E. and Wieland O. H. (1981) Specific quantification by HPLC of protein bound glucose in human serum albumin and other glycosylated proteins. J. Clin. Chem. Clin. Biochem. 19, 81-87.
76. Schmidt A. M., Vianna M., Gerlach M., Brett J., Ryan J., Esposito C., Hegarty H., Hurley W., Clauss M., Wang F., Yu-chiang E. P., Tsang C. and stren D. (1992) Isolation and characterisation of two binding proteins for AGE's from bovine lung which are present on the endothelial surface. J. biol. Chem. 267, 14987-14997.
77. Schnider S. L. and Kohn R. R. (1982) Effects of age and diabetes mellitus on the solubility of collagen from human skin, tracheal cartilage and dura mater. Exp. Gerontol. 17, 185-194.
78. Sell D. R., Lapolla A., Odetti P., Fogarty J. and Monnier V. M. (1992) Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 41, 1286-1292.
79. Sell D. R. and Monnier V. M. (1989a) Isolation, purification and partial characterization of novel flurophores from aging human insoluble collagen-rich tissue. Conn. Tiss. Res. 19, 77-92.
80. Sell D. R. and Monnier V. M. (1989b) Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J. biol. Chem. 264, 21597-21602.
81. Shaw S. M. and Crabbe M. J. C. (1994) Non-specific binding of advanced-glycosylation end-products to macrophages outweighs specific receptor-mediated interactions. Biochem. J. 304, 121-129.
82. Shepard D. C., Hitz J. B. and Dain J. A. (1985) Pyridoxal 5′-phosphate inhibits non-enzymatic glycosylation of proteins. Biochem. Arch. 1, 3, 143-151.
83. Shilton B. H., Campbell R. L. and Walton D. J. (1993) Site specificity of glycation of horse liver alcohol dehydrogenase in vitro. Eur. J. Biochem. 215, 3, 567-572.
84. Shilton B. H. and Walton D. J. (1991) Sites of glycation of human and horse liver alcohol dehydrogenase in vivo. J. biol. Chem. 266, 5587-5592.
85. Sims T. J. and Bailey A. J. (1992) Quantitative analysis of collagen and elastin cross-links using a single-column system. J. Chromatog. 582, 49-55.
86. Sims T. J., Rasmussen L. M., Oxlund H. and Bailey A. J. (1996) The role of glycation cross-links in diabetic vascular stiffening. Diabetologia. 39, 946-951.
87. Smith M. A., Taneda S., Richey P. L., Miyata S., Van S. D., Stern D., Sayre L. M., Monnier V. M. and Perry G. (1994) Advanced Maillard reaction end products are associated with Alzheimers disease pathology. Proc. Natl Acad. Sci. 91, 12, 5710-5714.
88. Smith P. R., Somani H. H., Thornalley P. J., Benn J. and Sonsken P. H. (1993) Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1 yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic glycation. Clin. Sci. 84, 87-93.
89. Swamy M. S. and Abraham E. C. (1989) Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo. Invest. Ophthalmol. Vis. Sci. 30, 1120-1126.
90. Tanaka S., Avigad G., Eikenberry E. F. and adn Brodsky B. (1988) Isolation and partial characterization of collagen chains dimerized by sugar-derived cross-links. J. biol. Chem. 263, 17650-17657.
91. Tsilibary E. C., Charonis A. S., Reger L. A., Wohlhueter R. M. and Furch L. T. (1988) The effect of non-enzymatic glucosylation on the binding of the main non-collagenous NC1 domain to type IV collagen. J. biol. Chem. 263, 9, 4302-4308.
92. Vlassara H., Brownlee M. and Cerami A. (1985) High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: A potential mechanism for the removal of senescent macromolecules. Proc. Natl Acad. Sci. 82, 23, 8274-8280.
93. Vlassara H., Striker L. J., Teichberg S., Fuh H., Li Y. M. and Steffes M. (1994) Advanced glycosylation end products induce sclerosis and albuminuria in normal rats. Proc. Natl Acad. Sci. 91, 11704-11708.
94. Wess T. J., Wess L., Miller A., Lindsay R. M. and Baird J. D. (1993) The in vivo glycation of diabetic tendon collagen studied by neutron diffraction. J. Mol. Biol. 230, 4, 1297-1303.
95. Winlove C. P., Parker K. H., Avery N. A. and Bailey A. J. (1996) Interactions of elastin and aorta with sugars in vitro and their effects on the biochemical and physical properties. Diabetologia. 39, 1131-1139.
96. Wolff S. P. and Dean R. T. (1987) Glucose autoxidation and protein modification. The potential role of autoxidative glycosylation in diabetes. Biochem. J. 245, 243-250.
97. Zyzak D. V., Richardson J. M., Thorpe S. R. and Baynes J. W. (1995) Formation of reactive intermediates from Amadori compounds under physiological conditions. Arch. Biochem. Biophys 316, 1, 547-554.
98. Zyzak D. V., Wells-Knecht K. J., Blackledge J. A., Litchfield J. E., Wells-Knecht M. C., Fu M.-X., Thorpe S. R., Feather M. S. and Baynes J. W. (1994) Pathways of the Maillard reaction in vitro and in vivo. In Maillard Reactions in Chemistry, Food, and Health (Eds Labuza T. P., Reineccius G. A., Monnier V. M., O'Brien J. and Baynes J. W.), pp. 274-280. The Royal Society of Chemistry, Cambridge.